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hospital characteristics, patterns of medication used, and
outcome measures. Multivariate analyses such as general
linear model (GLM) and logistic regression were per-
formed. RESULTS: Logistic regression results show that
hospital size (p < 0.0001), hospital type (p < 0.0472), type
of procedure (p < 0.0001), and hospitals having a care-
plan for surgical site infection (p < 0.0032) were signiﬁ-
cantly associated with the probability for patients to get
the recommended prophylaxis. Based on the results from
GLM regression analysis, older age is signiﬁcantly asso-
ciated with longer LOS (p < 0.0001) for all procedures.
Scheduled operations (p < 0.0001) and receiving the rec-
ommended prophylaxis (p < 0.0214) were signiﬁcantly
related to a decrease in LOS. Also, a signiﬁcant effect on
LOS was observed, depending what kind of surgical pro-
cedure patients underwent and what hospital they were
admitted. CONCLUSIONS: Compliance with practice
guidelines may reduce LOS, which suggests improved
patient outcomes and decreased health care costs.
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OBJECTIVE: A cost-beneﬁt analysis was conducted to
compare the costs associated with operating a poison
center to the beneﬁts derived from center availability.
METHODS: Costs were measured as the direct cost of
operating the center, including personnel, reference
sources for clinical information, equipment, and admin-
istrative overhead expenses. Beneﬁts were measured as
the opportunity cost of alternative treatment strategies
had a poison center not been available to callers. Data
were collected through a concurrent telephone survey of
poison center callers at the time of the initial poison expo-
sure call. Callers were asked a series of three questions
regarding actions they would have taken if the poison
center were not available. Follow-up calls were used to
assess actions callers actually took after calling the center.
Inputs and beneﬁts were valued using average local prices
for medical services from a state paid claims database. A
decision analysis model was constructed to calculate the
expected cost of poison treatments under two scenarios
(poison center available or not). Model probabilities were
derived from the percentage of callers indicating that they
would pursue a particular course of action. RESULTS: A
total of 1695 poison exposure cases were included in the
analysis. The average cost per poison exposure associated
with not having a poison center available was $62.40.
This ﬁgure represents the beneﬁt of having a poison
center. The average cost of managing a poison call was
$8.52, yielding a beneﬁt per call ratio of $7.32. This ratio
reﬂects the amount of additional health care expenditures
avoided per dollar expended in a poison center consulta-
tion. A sensitivity analysis was conducted to assess the
impact of changes in emergency service use on the model.
CONCLUSION: Based on our analysis, the immediate
information and treatment advice available through a
state-run poison center has as a positive societal value.
PHP29
WHERE DOES THE GERMAN HEALTH CARE
SYSTEM WANT TO GO TO?
Naujoks C1, Kohlmann T2
1Novartis Pharma AG, Basel, Switzerland; 2University of
Greifswald, Greifswald, MV, Germany
OBJECTIVES: The focus of present health political dis-
cussion in Germany is concentrated on ﬁnancing as an
instrument to meet the future needs of German popula-
tion. Government wants to cut back beneﬁts by offering
alternative funding mechanism, which is tax ﬁnancing
and additional patient payments. The recent and signiﬁ-
cant changes to Health care funding in Germany is
reviewed. METHODS: A literature review was conducted
to analyze a number of strengths to the ﬁnancing and
funding arrangements in the German Health care system.
The potential advantages for priorities, efﬁciency, and
equity from this structure of ﬁnancing are considered. The
results will be compared to the design of the currently
started plans for a further Health care reform in Germany
with focus on ﬁnancing. RESULTS: The current most
important scheme of social health insurance (SHI) ﬁnance
intended to mobilize resources for health care, to insure
against risk, and to provide stable ﬁnance seems for the
government not to be any longer the funding mechanism
that helps to control costs and to secure access to broad
priority services. Government intends to use ﬁnance
mechanism to shift low priority services into SHI and put
high priority services into ﬁnance mechanism of user
charges. The level of priority services is—so far—not a
result of discussions in the community. Financial fairness
is best served by the cornerstone of more progressive 
prepayments as it is the case for SHI premiums instead 
of patient payments. Co-payments have the effect of
rationing use health care services but does not effect in
rationalizing its demand by insured. CONCLUSIONS:
Currently risks are distributed according to ability to pay
rather than to risk of disease. Financing fairness is best
served by the cornerstone of progressive prepayments 
as it is the case for SHI premiums instead of patient 
payments.
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OBJECTIVE: Although tube feeding is commonly used in
hospitals in the UK, clinician interviews showed that no
